Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biomedical Translational Research Institute (BTRI) is a South Korean contract research organization (CRO) that provides comprehensive clinical trial services to the pharmaceutical, biotechnology, and medical device industries. Founded in 2012, the company specializes in clinical trial management, regulatory affairs, medical writing, and data management. BTRI supports all phases of clinical development, from Phase I through Phase IV, as well as post-marketing surveillance (PMS). The company is headquartered in Seoul and focuses on bridging the gap between laboratory research and clinical application through high-quality translational research services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biomedical Translational Research Institute.